Chris Amemiya

Title: Chris Amemiya: Innovator in Variable Lymphocyte Receptors

Introduction

Chris Amemiya is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of immunology, particularly through his work on variable lymphocyte receptors. With a total of 2 patents, Amemiya's innovations have the potential to impact various applications in medical research and treatment.

Latest Patents

Amemiya's latest patents include compositions and methods related to variable lymphocyte receptors (VLRs). The first patent focuses on variable lymphocyte receptors, related polypeptides, and nucleic acids, detailing the compositions and methods associated with VLRs. The second patent also addresses variable lymphocyte receptors, further expanding the understanding and potential applications of these important biological components.

Career Highlights

Throughout his career, Chris Amemiya has worked with notable organizations such as the UAB Research Foundation and the Benaroya Research Institute. His work in these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in immunology.

Collaborations

Amemiya has collaborated with esteemed colleagues, including Zeev Pancer and Max Dale Cooper. These partnerships have fostered a rich environment for innovation and discovery in the field of variable lymphocyte receptors.

Conclusion

Chris Amemiya's contributions to the field of immunology through his patents and collaborations highlight his role as a key innovator. His work on variable lymphocyte receptors continues to pave the way for advancements in medical research and treatment.